The advent of immunotherapy based on immune checkpoint inhibitors has improved the treatment of advanced hepatocellular ...

For several years, investigators have been studying combinations that include ruxolitinib, sold as Jakafi, to treat ...

CureVac recently released new clinical data. Why should investors care? Click here to find out why I am bullish on CVAC stock ...

With an aggregate of $11 million raised in an initial Series A funding round, Doron Therapeutics is advancing its lead ...

The FDA cleared the investigational new drug application for REC-4539, allowing for the start of a phase 1/2 trial in small ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

Seed has revealed its token supply and final mining tasks, ahead of the Telegram game's token launch and airdrop on Sui.

Ellen Green, a postgraduate researcher with the University of Reading, analyzed “Quarry 1” from the Nescot site and found “it ...

Women who used the Continuous Precision Medicine mobile application had a lower likelihood of misusing prescription opioids ...

Vision Net, a leading provider of network and technology solutions for carriers, enterprise businesses, healthcare organizations, and educational institutions, announced a series of significant ...

The city of Chico announced that it has been awarded a $12,746,798 grant to fund an innovative fiber utility project aimed at ...

Viking Therapeutics (VKTX) announced the initiation of a Phase 2 clinical trial of the oral tablet formulation of VK2735, the company’s dual ...